| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 菜油甾醇; Campesterol | CFN92204 | 474-62-4 | C28H48O = 400.7 | 10mg | QQ客服：3257982914 |
| Delta 5-avenasterol; Delta 5-avenasterol | CFN92239 | 18472-36-1 | C29H48O = 412.7 | 5mg | QQ客服：215959384 |
| Delta 7-avenasterol; Delta 7-avenasterol | CFN92240 | 23290-26-8 | C29H48O = 412.7 | 5mg | QQ客服：2056216494 |
| 麦冬皂苷D'; Ophiopogonin D' | CFN90503 | 65604-80-0 | C44H70O16 = 855.02 | 10mg | QQ客服：1457312923 |
| 牛膝甾酮; Inokosterone | CFN92515 | 15130-85-5 | C27H44O7 = 480.6 | 5mg | QQ客服：2159513211 |
| 杠柳毒苷; Periplocin | CFN90513 | 13137-64-9 | C36H56O13 = 696.82 | 20mg | QQ客服：1413575084 |
| 杠柳苷元; Periplogenin | CFN90514 | 514-39-6 | C23H34O5 = 390.51 | 20mg | QQ客服：2056216494 |
| 漏芦甾酮 B; Rhapontisterone B | CFN90522 | 698975-64-3 | C27H44O7 = 480.63 | 5mg | QQ客服：3257982914 |
| Glucopyranoside,(3beta,25R)-17-hydroxyspirost-5-en-3-yl; Glucopyranoside,(3beta,25R)-17-hydroxyspirost-5-en-3-yl | CFN92807 | 84914-58-9 | C44H70O17 = 870.5 | 10mg | QQ客服：2159513211 |
| 洋地黄皂苷，毛地黄皂苷; Digitonin | CFN92831 | 11024-24-1 | C56H92O29 = 1229.3 | 20mg | QQ客服：2159513211 |
| 山麦冬皂苷B; Lirioprolioside B | CFN90599 | 182284-68-0 | C41H64O13 = 764.95 | 5mg | QQ客服：2056216494 |
| 苦绳苷D; Dregeoside Da1 | CFN97890 | 98665-65-7 | C42H70O15 = 815.0 | 5mg | QQ客服：215959384 |
| 豆甾-4,22-二烯-3beta,6beta-二醇; Stigmasta-4,22-diene-3beta,6beta-diol | CFN97930 | 167958-89-6 | C29H48O2 = 428.7 | 5mg | QQ客服：1457312923 |
| 苦绳苷A11; Dregeoside A11 | CFN96087 | 89020-11-1 | C55H88O22 = 1101.3 | 5mg | QQ客服：1457312923 |
| 去乙酰华蟾毒精; Deacetylcinobufagin | CFN90579 | 4026-95-3 | C24H32O5 = 400.52 | 10mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)